• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Endocrine . Association between glycemic control and the outcome in hospitalized patients with COVID-19

tetano

Editor, Senior Moderator
Endocrine


. 2022 May 21.
doi: 10.1007/s12020-022-03078-9. Online ahead of print.
Association between glycemic control and the outcome in hospitalized patients with COVID-19


Jamil Muqtadir Bhatti[SUP] 1 2 [/SUP], Syed Ali Raza[SUP] 3 4 [/SUP], Muhammad Owais Shahid[SUP] 3 [/SUP], Ayesha Akhtar[SUP] 3 [/SUP], Tauseef Ahmed[SUP] 3 4 [/SUP], Bhagwan Das[SUP] 4 5 [/SUP]



Affiliations

Abstract

Purpose: Coronavirus disease 2019 (COVID-19) clinical outcome and disease severity affected by several factors; deterioration of glycemic control is one of them. Therefore, achieving optimum blood glucose parameters is hypothesized for better consequences of COVID-19. However, varying data supporting this hypothesis is available in literature. The intention of this study was to investigate the role of glycemic management on the prognosis of hospitalized COVID-19 patients with varying degrees of severity.
Methods: From April 2020 to January 2021, we carried this retrospective cohort in a clinical care facility in Pakistan.
Results: Mortality was lowest in patients with HbA1c of less than 7% (53 mmol/mol) (p < 0.001). Similarly, mortality was found lowest in patients with fasting blood glucose less than 126 mg/dl and random blood glucose less than 160 mg/dl (p < 0.001 in each). In contrast, need for admission in critical care was found highest in patients with HbA1c between 7 and 10% (53-86 mmol/mol) (p 0.002). However, participants with blood glucose levels during fasting greater than 200 mg/dl and random blood glucose levels greater than 250 mg/dl were found to have a greater need for invasive mechanical ventilation. Cox regression hazard showed no difference in risk of death and invasive mechanical ventilation based on previous glycemic control.
Conclusion: Effective diabetic management is correlated with a considerably lower risk of mortality and invasive mechanical ventilation in COVID-19 cases.

Keywords: COVID-19; HbA1c; diabetes mellitus; intensive care unit; invasive mechanical ventilation; mortality.
 
Back
Top Bottom